Biotechnology company Calysta is targeting the growing pet food market in Europe.

The new treat represents the first commercial inclusion of Calysta’s FeedKind® Pet protein.

The company’s FeedKind ingredient has been approved by the FDA’s CVM for use in salmon feed.

The sustainable protein producer has begun planning for a new facility located in Al Jubail.

The facility produces FeedKind, a fermented protein ingredient that does not use any animal- nor plant-based materials.

The company has appointed Herman Sloot to vice president of commercial development.

The facility is located in China and will produce FeedKind for use in aquaculture and food industries.